Office of Clinical Policy, Food and Drug Administration
Bridget Foltz is a Policy Analyst in the Office of Clinical Policy, the focal point within FDA for good clinical practice and human subject protection issues arising in human research trials regulated by the Agency. She has been with FDA for over 18 years holding previous positions in the Center for Devices and Radiological Health (CDRH) and Center for Biologics Evaluation and Research (CBER). Bridget has prior experience in both the pharmaceutical and device industries. She has an M.S. in Biotechnology from Johns Hopkins University.
Disclosure information not submitted.
Thursday, November 18, 2021
1:30 PM – 2:30 PM ET